Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 9.2B | 8.8B | 9.7B | 9.0B |
Cost of revenue | 5.5B | 5.2B | 5.6B | 5.3B |
Gross profit | 3.8B | 3.6B | 4.1B | 3.7B |
Operating expense | ||||
Research & development | 300.0M | 291.5M | 318.7M | 294.9M |
Selling general and admin | 1.8B | 1.8B | 1.9B | 1.8B |
Other operating expenses | — | — | — | — |
Operating income | 1.6B | 1.5B | 1.9B | 1.6B |
Non operating interest income | ||||
Income | 253.1M | 173.0M | 193.4M | 236.1M |
Expense | 344.3M | 258.2M | 270.1M | 303.4M |
Other income expense | -86.1M | -81.0M | -182.4M | -52.0M |
Pretax income | 1.5B | 1.4B | 1.7B | 1.5B |
Tax provision | 78.4M | 81.0M | 127.8M | 84.4M |
Net income | 1.4B | 1.3B | 1.6B | 1.4B |
Basic EPS | 4.3 | 4.0 | 4.8 | 4.3 |
Diluted EPS | 4.3 | 4.0 | 4.8 | 4.3 |
Basic average shares | 322.1M | 322.1M | 325.5M | 325.5M |
Diluted average shares | 322.1M | 323.0M | 326.4M | 327.2M |
EBITDA | 2.5B | 2.3B | 2.7B | 2.5B |
Net income from continuing op. | 1.4B | 1.3B | 1.6B | 1.4B |
Minority interests | -1.7M | -3.4M | 5.1M | 0 |
Preferred stock dividends | — | — | — | — |